Annual report
9220.TEDINET S100YK1M
Period2025-04-01 → 2026-03-31
Filed2026-06-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 147
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥11.5bn | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥11.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥10.4bn | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥9.6bn | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥9.2bn | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Operating income | ¥635m | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥660m | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥826m | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥679m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥802m | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥737m | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥648m | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥685m | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥595m | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥464m | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥406m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥523m | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥445m | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥529m | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥464m | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥406m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥9.3bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥8.9bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥9.5bn | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥9.0bn | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥7.7bn | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.4bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥5.2bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.9bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.6bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.5bn | at 2024-03-31v | Cons. | Net assets |
| Net assets / equity | ¥3.0bn | at 2023-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥2.0bn | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.2bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.0bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.9bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.8bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2023-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.6bn | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.3bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.1bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥970m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥899m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥411m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥240m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥586m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥849m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥97m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥767m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.2bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥472m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥464m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥879m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥187.51 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥152 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥195.6 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥167.39 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥240.32 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥1,612.43 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,447.37 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,299.91 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,135.13 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥913.16 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 42.1% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.1% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.6% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.7% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.1% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 12.3% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.4% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 16.1% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 17.6% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 30.3% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 993 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 1,001 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 1,060 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 1,011 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 985 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥10.8bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥10.3bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥9.8bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥9.3bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥8.8bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥619m | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥647m | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥799m | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥657m | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥767m | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥713m | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥578m | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥658m | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥573m | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥438m | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥393m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥519m | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥461m | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥368m | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥9.1bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥8.6bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥9.3bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥8.9bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥7.5bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥5.3bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥5.1bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥3.8bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥3.5bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥3.4bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥2.9bn | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.9bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.9bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.7bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥176.8 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥147.19 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥194.05 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥173.29 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥167.07 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥38 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥33 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥33 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥33 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,553.55 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,400.89 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,261.02 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,097.79 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥860.61 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 41.7% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.8% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.3% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.2% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.2% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 12.0% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.4% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.5% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 19.1% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 21.5% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 2,436,700 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,676,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,676,000 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,676,000 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,200,000 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 923 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 939 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 979 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 952 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 938 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2025-04-01 → 2026-03-31 | ¥62m |
| Reconciling Itemsreconciling | segment assets | at 2026-03-31 | ¥2.9bn |
| Nursing Care Businessreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥329m |
| Nursing Care Businessreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥344m |
| Nursing Care Businessreportable segment | employees | at 2026-03-31 | 665 pure |
| Nursing Care Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥6.6bn |
| Nursing Care Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥6.6bn |
| Nursing Care Businessreportable segment | segment assets | at 2026-03-31 | ¥5.0bn |
| Nursing Care Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥314m |
| Nursing Care Equipment Businessreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥229m |
| Nursing Care Equipment Businessreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥42m |
| Nursing Care Equipment Businessreportable segment | employees | at 2026-03-31 | 276 pure |
| Nursing Care Equipment Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥5.0bn |
| Nursing Care Equipment Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥5.0bn |
| Nursing Care Equipment Businessreportable segment | segment assets | at 2026-03-31 | ¥1.5bn |
| Nursing Care Equipment Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥321m |
| —segment total | capex | 2025-04-01 → 2026-03-31 | ¥558m |
| —segment total | depreciation | 2025-04-01 → 2026-03-31 | ¥387m |
| —segment total | revenue | 2025-04-01 → 2026-03-31 | ¥11.5bn |
| —segment total | revenue external | 2025-04-01 → 2026-03-31 | ¥11.5bn |
| —segment total | segment assets | at 2026-03-31 | ¥6.5bn |
| —segment total | segment profit | 2025-04-01 → 2026-03-31 | ¥635m |
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥940,000 |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥2.5bn |
| Nursing Care Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥247m |
| Nursing Care Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥344m |
| Nursing Care Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥6.4bn |
| Nursing Care Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥6.4bn |
| Nursing Care Businessreportable segment | segment assets | at 2025-03-31 | ¥5.1bn |
| Nursing Care Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥346m |
| Nursing Care Equipment Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥3m |
| Nursing Care Equipment Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥30m |
| Nursing Care Equipment Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥4.6bn |
| Nursing Care Equipment Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥4.6bn |
| Nursing Care Equipment Businessreportable segment | segment assets | at 2025-03-31 | ¥1.2bn |
| Nursing Care Equipment Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥314m |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥250m |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥374m |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥11.0bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥11.0bn |
| —segment total | segment assets | at 2025-03-31 | ¥6.3bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥660m |
| Nursing Care Businessreportable segment | employees | at 2026-03-31 | 598 pure |
| Nursing Care Equipment Businessreportable segment | employees | at 2026-03-31 | 273 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,499
| Item | Context | Value | Unit |
|---|---|---|---|
| Edinet code | FilingDateInstant | E37523 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 92200 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)エフビー介護サービス株式会社 | |
| Filer name in english | FilingDateInstant | FB CARE SERVICE CO.,LTD. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第三号様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Current fiscal year start date | FilingDateInstant | 2025-04-01 | |
| Current period end date | FilingDateInstant | 2026-03-31 | |
| Type of current period | FilingDateInstant | FY | |
| Current fiscal year end date | FilingDateInstant | 2026-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2024-04-01 | |
| Comparative period end date | FilingDateInstant | 2025-03-31 | |
| Previous fiscal year end date | FilingDateInstant | 2025-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Company history (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Overview of affiliated entities (text) | FilingDateInstant | Text · Plus | |
| Business policy business environment issues to address etc (text) | FilingDateInstant | Text · Plus | |
| Disclosure of sustainability related financial information (text) | FilingDateInstant | Text · Plus | |
| Governance (text) | FilingDateInstant | Text · Plus | |
| Risk management (text) | FilingDateInstant | Text · Plus | |
| Strategy (text) | FilingDateInstant | Text · Plus | |
| Metrics and targets (text) | FilingDateInstant | Text · Plus | |
| Policy on development of human resources and internal environment strategy (text) | FilingDateInstant | Text · Plus | |
| Description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics metrics and targets (text) | FilingDateInstant | Text · Plus | |
| Metrics description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row1Member | Original text (Japanese)管理的地位にある労働者に占める女性労働者の割合 | |
| Metrics unit description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row1Member | ％ | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts (text) | FilingDateInstant | Text · Plus | |
| Research and development activities (text) | FilingDateInstant | Text · Plus | |
| Overview of capital expenditures etc (text) | FilingDateInstant | Text · Plus | |
| Major facilities (text) | FilingDateInstant | Text · Plus | |
| Planned additions retirements etc of facilities (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |